Mina Ardestani, Zahra Khorsandi, Fariba Keshavarzipour, Siavash Iravani, Hojjat Sadeghi-Aliabadi, & Rajender S. Varma. (2022). Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications. MDPI AG.
Chicago Style (17th ed.) CitationMina Ardestani, Zahra Khorsandi, Fariba Keshavarzipour, Siavash Iravani, Hojjat Sadeghi-Aliabadi, and Rajender S. Varma. Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications. MDPI AG, 2022.
MLA (9th ed.) CitationMina Ardestani, et al. Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.